QQQ   324.08 (-0.57%)
AAPL   168.49 (-0.44%)
MSFT   287.02 (-0.74%)
META   177.49 (-0.48%)
GOOGL   118.84 (-0.72%)
AMZN   140.64 (-1.44%)
TSLA   859.89 (-2.62%)
NVDA   179.42 (-0.86%)
NIO   20.82 (+3.84%)
BABA   94.87 (+2.64%)
AMD   98.12 (-0.94%)
MU   62.32 (+1.50%)
T   18.04 (+0.17%)
CGC   3.15 (-4.26%)
GE   78.90 (+2.28%)
F   15.83 (+2.13%)
DIS   117.69 (+4.68%)
AMC   25.46 (+7.56%)
PYPL   99.11 (+0.20%)
PFE   48.29 (-3.32%)
NFLX   242.70 (-0.58%)
QQQ   324.08 (-0.57%)
AAPL   168.49 (-0.44%)
MSFT   287.02 (-0.74%)
META   177.49 (-0.48%)
GOOGL   118.84 (-0.72%)
AMZN   140.64 (-1.44%)
TSLA   859.89 (-2.62%)
NVDA   179.42 (-0.86%)
NIO   20.82 (+3.84%)
BABA   94.87 (+2.64%)
AMD   98.12 (-0.94%)
MU   62.32 (+1.50%)
T   18.04 (+0.17%)
CGC   3.15 (-4.26%)
GE   78.90 (+2.28%)
F   15.83 (+2.13%)
DIS   117.69 (+4.68%)
AMC   25.46 (+7.56%)
PYPL   99.11 (+0.20%)
PFE   48.29 (-3.32%)
NFLX   242.70 (-0.58%)
QQQ   324.08 (-0.57%)
AAPL   168.49 (-0.44%)
MSFT   287.02 (-0.74%)
META   177.49 (-0.48%)
GOOGL   118.84 (-0.72%)
AMZN   140.64 (-1.44%)
TSLA   859.89 (-2.62%)
NVDA   179.42 (-0.86%)
NIO   20.82 (+3.84%)
BABA   94.87 (+2.64%)
AMD   98.12 (-0.94%)
MU   62.32 (+1.50%)
T   18.04 (+0.17%)
CGC   3.15 (-4.26%)
GE   78.90 (+2.28%)
F   15.83 (+2.13%)
DIS   117.69 (+4.68%)
AMC   25.46 (+7.56%)
PYPL   99.11 (+0.20%)
PFE   48.29 (-3.32%)
NFLX   242.70 (-0.58%)
QQQ   324.08 (-0.57%)
AAPL   168.49 (-0.44%)
MSFT   287.02 (-0.74%)
META   177.49 (-0.48%)
GOOGL   118.84 (-0.72%)
AMZN   140.64 (-1.44%)
TSLA   859.89 (-2.62%)
NVDA   179.42 (-0.86%)
NIO   20.82 (+3.84%)
BABA   94.87 (+2.64%)
AMD   98.12 (-0.94%)
MU   62.32 (+1.50%)
T   18.04 (+0.17%)
CGC   3.15 (-4.26%)
GE   78.90 (+2.28%)
F   15.83 (+2.13%)
DIS   117.69 (+4.68%)
AMC   25.46 (+7.56%)
PYPL   99.11 (+0.20%)
PFE   48.29 (-3.32%)
NFLX   242.70 (-0.58%)
NYSE:USPH

U.S. Physical Therapy - USPH Stock Forecast, Price & News

$90.37
+0.83 (+0.93%)
(As of 08/11/2022 12:00 AM ET)
Add
Compare
Today's Range
$90.24
$93.44
50-Day Range
$88.97
$130.18
52-Week Range
$84.43
$131.50
Volume
138,624 shs
Average Volume
82,614 shs
Market Capitalization
$1.17 billion
P/E Ratio
30.84
Dividend Yield
1.83%
Price Target
$121.50

U.S. Physical Therapy MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
34.4% Upside
$121.50 Price Target
Short Interest
Bearish
5.50% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
N/A
News Sentiment
-0.24mentions of U.S. Physical Therapy in the last 14 days
Based on 10 Articles This Week
Insider Trading
Selling Shares
$352,172 Sold Last Quarter
Proj. Earnings Growth
11.11%
From $2.70 to $3.00 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.76 out of 5 stars

Medical Sector

46th out of 1,112 stocks

Health Services Industry

1st out of 12 stocks

USPH stock logo

About U.S. Physical Therapy (NYSE:USPH) Stock

U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. As of December 31, 2021, it operated 591 clinics in 39 states; and managed 35 physical therapy practice facilities. The company was founded in 1990 and is based in Houston, Texas.

U.S. Physical Therapy Stock Performance

Shares of NYSE:USPH traded up $1.94 during midday trading on Thursday, reaching $91.48. 105 shares of the company's stock traded hands, compared to its average volume of 101,112. The company has a market cap of $1.19 billion, a price-to-earnings ratio of 30.56 and a beta of 1.22. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.08 and a current ratio of 1.43. U.S. Physical Therapy has a one year low of $84.43 and a one year high of $131.50. The stock has a 50 day moving average of $113.37 and a 200 day moving average of $104.74.

U.S. Physical Therapy (NYSE:USPH - Get Rating) last issued its quarterly earnings results on Thursday, August 4th. The company reported $0.90 EPS for the quarter, missing analysts' consensus estimates of $0.93 by ($0.03). U.S. Physical Therapy had a return on equity of 14.22% and a net margin of 7.62%. The company had revenue of $140.70 million during the quarter, compared to analysts' expectations of $143.01 million. During the same quarter in the previous year, the company earned $0.96 EPS. The business's quarterly revenue was up 10.9% compared to the same quarter last year. As a group, equities research analysts anticipate that U.S. Physical Therapy will post 2.7 EPS for the current fiscal year.

U.S. Physical Therapy Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, September 16th. Stockholders of record on Thursday, August 18th will be issued a $0.41 dividend. The ex-dividend date is Wednesday, August 17th. This represents a $1.64 annualized dividend and a dividend yield of 1.79%. U.S. Physical Therapy's payout ratio is 55.97%.

Wall Street Analyst Weigh In

Separately, TheStreet upgraded U.S. Physical Therapy from a "c+" rating to a "b-" rating in a research report on Thursday, July 28th.

Insiders Place Their Bets

In related news, Director Anne Motsenbocker purchased 500 shares of the business's stock in a transaction dated Tuesday, August 9th. The shares were acquired at an average cost of $92.29 per share, for a total transaction of $46,145.00. Following the acquisition, the director now owns 2,600 shares of the company's stock, valued at approximately $239,954. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In related news, Director Anne Motsenbocker acquired 500 shares of the firm's stock in a transaction dated Tuesday, August 9th. The stock was acquired at an average price of $92.29 per share, with a total value of $46,145.00. Following the acquisition, the director now directly owns 2,600 shares in the company, valued at approximately $239,954. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, COO Graham D. Reeve sold 3,818 shares of U.S. Physical Therapy stock in a transaction dated Monday, August 8th. The shares were sold at an average price of $92.24, for a total value of $352,172.32. Following the completion of the transaction, the chief operating officer now owns 16,191 shares of the company's stock, valued at approximately $1,493,457.84. The disclosure for this sale can be found here. 1.90% of the stock is currently owned by company insiders.

Receive USPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for U.S. Physical Therapy and its competitors with MarketBeat's FREE daily newsletter.

USPH Stock News Headlines

U.S. Physical Therapy (NYSE:USPH) Lifted to "B-" at TheStreet
U.S. Physical Therapy: Outpatient Pure Play
See More Headlines
Receive USPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for U.S. Physical Therapy and its competitors with MarketBeat's FREE daily newsletter.

USPH Company Calendar

Ex-Dividend for 6/14 Dividend
5/13/2022
Dividend Payable
6/14/2022
Last Earnings
8/04/2022
Today
8/11/2022
Ex-Dividend for 9/16 Dividend
8/17/2022
Dividend Payable
9/16/2022
Next Earnings (Estimated)
11/03/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Health services
Sub-Industry
Health Care Facilities
Sector
Medical
CUSIP
90337L10
Employees
5,500
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$121.50
High Stock Price Forecast
$123.00
Low Stock Price Forecast
$120.00
Forecasted Upside/Downside
+34.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$40.83 million
Pretax Margin
13.50%

Debt

Sales & Book Value

Annual Sales
$495.02 million
Cash Flow
$4.90 per share
Book Value
$23.76 per share

Miscellaneous

Free Float
12,744,000
Market Cap
$1.17 billion
Optionable
Optionable
Beta
1.22

Key Executives














USPH Stock - Frequently Asked Questions

Should I buy or sell U.S. Physical Therapy stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for U.S. Physical Therapy in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" USPH shares.
View USPH analyst ratings
or view top-rated stocks.

What is U.S. Physical Therapy's stock price forecast for 2022?

2 analysts have issued 12-month price objectives for U.S. Physical Therapy's shares. Their USPH share price forecasts range from $120.00 to $123.00. On average, they expect the company's share price to reach $121.50 in the next twelve months. This suggests a possible upside of 32.8% from the stock's current price.
View analysts price targets for USPH
or view top-rated stocks among Wall Street analysts.

How have USPH shares performed in 2022?

U.S. Physical Therapy's stock was trading at $95.55 on January 1st, 2022. Since then, USPH shares have decreased by 4.3% and is now trading at $91.46.
View the best growth stocks for 2022 here
.

When is U.S. Physical Therapy's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 3rd 2022.
View our USPH earnings forecast
.

How were U.S. Physical Therapy's earnings last quarter?

U.S. Physical Therapy, Inc. (NYSE:USPH) posted its quarterly earnings results on Thursday, August, 4th. The company reported $0.90 earnings per share for the quarter, missing the consensus estimate of $0.93 by $0.03. The company had revenue of $140.70 million for the quarter, compared to analysts' expectations of $143.01 million. U.S. Physical Therapy had a trailing twelve-month return on equity of 14.22% and a net margin of 7.62%. The company's revenue was up 10.9% on a year-over-year basis. During the same quarter last year, the company earned $0.96 earnings per share.

How often does U.S. Physical Therapy pay dividends? What is the dividend yield for U.S. Physical Therapy?

U.S. Physical Therapy announced a quarterly dividend on Thursday, August 4th. Stockholders of record on Thursday, August 18th will be paid a dividend of $0.41 per share on Friday, September 16th. This represents a $1.64 annualized dividend and a yield of 1.79%. The ex-dividend date of this dividend is Wednesday, August 17th.
Read our dividend analysis for USPH
.

Is U.S. Physical Therapy a good dividend stock?

U.S. Physical Therapy (NYSE:USPH) pays an annual dividend of $1.64 per share and currently has a dividend yield of 1.84%. The company has been increasing its dividend for 3 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio is 55.97%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, USPH will have a dividend payout ratio of 54.67% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for USPH.

What guidance has U.S. Physical Therapy issued on next quarter's earnings?

U.S. Physical Therapy issued an update on its FY 2022 earnings guidance on Thursday, August, 11th. The company provided earnings per share (EPS) guidance of $2.65-$2.75 for the period. The company issued revenue guidance of -.

What is Chris Reading's approval rating as U.S. Physical Therapy's CEO?

38 employees have rated U.S. Physical Therapy Chief Executive Officer Chris Reading on Glassdoor.com. Chris Reading has an approval rating of 49% among the company's employees. This puts Chris Reading in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of U.S. Physical Therapy own?

Based on aggregate information from My MarketBeat watchlists, some companies that other U.S. Physical Therapy investors own include Pfizer (PFE), NVIDIA (NVDA), AbbVie (ABBV), CVS Health (CVS), Gilead Sciences (GILD), International Business Machines (IBM), Illumina (ILMN), Johnson & Johnson (JNJ), Lowe's Companies (LOW) and Marathon Petroleum (MPC).

What is U.S. Physical Therapy's stock symbol?

U.S. Physical Therapy trades on the New York Stock Exchange (NYSE) under the ticker symbol "USPH."

Who are U.S. Physical Therapy's major shareholders?

U.S. Physical Therapy's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Copeland Capital Management LLC (3.99%), Boston Trust Walden Corp (3.50%), Riverbridge Partners LLC (3.31%), Principal Financial Group Inc. (0.70%), Envestnet Asset Management Inc. (0.69%) and JPMorgan Chase & Co. (0.69%). Insiders that own company stock include Anne Motsenbocker, Bernard A Harris Jr, Bernard A Harris, Jr, Christopher J Reading, Christopher J Reading, Clayton Trier, Edward L Kuntz, Eric Joseph Williams, Glenn Mcdowell, Graham D Reeve, Graham D Reeve, Harry S Chapman, Harry S Chapman, Kathleen A Gilmartin, Lawrance W Mcafee, Mark J Brookner and Regg E Swanson.
View institutional ownership trends
.

How do I buy shares of U.S. Physical Therapy?

Shares of USPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is U.S. Physical Therapy's stock price today?

One share of USPH stock can currently be purchased for approximately $91.46.

How much money does U.S. Physical Therapy make?

U.S. Physical Therapy (NYSE:USPH) has a market capitalization of $1.19 billion and generates $495.02 million in revenue each year. The company earns $40.83 million in net income (profit) each year or $2.93 on an earnings per share basis.

How many employees does U.S. Physical Therapy have?

The company employs 5,500 workers across the globe.

How can I contact U.S. Physical Therapy?

U.S. Physical Therapy's mailing address is 1300 WEST SAM HOUSTON PARKWAY SUITE 300, HOUSTON TX, 77042. The official website for the company is www.usph.com. The company can be reached via phone at (713) 297-7000, via email at lmcafee@usph.com, or via fax at 713-297-7090.

This page (NYSE:USPH) was last updated on 8/11/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.